Info

MTI was the first company to receive approval for generic Nitroglycerin, Estradiol and Fentanyl transdermal systems. Our scientists also aided in the development of EMSAM® (selegiline transdermal system). And today, EMSAM® is manufactured by MTI. Mylan Technologies Inc. also produces components for the medical device and transdermal industries. Our unmatched expertise, reputation for exceptional quality and ability to develop components are a catalyst for innovative and proprietary healthcare products.